{{Rsnum
|rsid=3747851
|Gene=DAB2IP
|Chromosome=9
|position=121758981
|Orientation=minus
|GMAF=0.06107
|Gene_s=DAB2IP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 99.1 | 0.9 | 0.0
| HCB | 72.3 | 26.3 | 1.5
| JPT | 57.5 | 33.6 | 8.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 72.3 | 26.3 | 1.5
| CHD | 69.7 | 24.8 | 5.5
| GIH | 98.0 | 2.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 81.0 | 17.2 | 1.7
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=6E-7
  |OR=2.38
  |ORtxt=[1.693-3.339]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}